Human VEGF-A(Vascular Endothelial Cell Growth Factor A) ELISA Kit
中文名称:人血管内皮细胞生长因子A(VEGF-A)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 31.25-2000 pg/mL
- 灵敏度: 18.75 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人VEGF-A抗体包被于酶标板上,实验时样品(或标准品)中的人VEGF-A会与包被抗体结合。后依次加入生物素化的抗人VEGF-A抗体和辣根过氧化物酶标记的亲和素,抗人VEGF-A抗体与结合在包被抗体上的人VEGF-A结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,VEGF-A浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中VEGF-A的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 31.25-2000 pg/mL |
灵敏度 | 18.75 pg/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人VEGF-A,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF-1α Ubiquitination and Degradation
IF: 14.300 -
Biomimetic Triplet Messenger RNA Formulation in MXene Hydrogel Microneedles for Wound Healing
IF: 13.900 -
Liquid metal hybrid antibacterial hydrogel scaffolds from 3D printing for wound healing
IF: 13.300 -
A tetrahedral DNA nanostructure-mediated miRNA inhibitor delivery system: Type H vessel-related bone healing during distraction osteogenesis
IF: 13.300 -
Smart multifunctional Cu2O@RuO2 nanozyme for angiogenesis and osteogenesis in periodontitis
IF: 13.200 -
Repair spinal cord injury with a versatile anti-oxidant and neural regenerative nanoplatform
IF: 10.600 -
A single dose of VEGF-A circular RNA sustains in situ long-term expression of protein to accelerate diabetic wound healing
IF: 10.500 -
Ligand-Selective Targeting of Macrophage Hydrogel Elicits Bone Immune-Stem Cell Endogenous Self-Healing Program to Promote Bone Regeneration
IF: 10.000 -
Self-Assembled Peptide Hydrogels Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells Repairing Injured Endometrium and Restoring Fertility
IF: 10.000 -
Janus adhesive microneedle patch loaded with exosomes for intrauterine adhesion treatment
IF: 7.000